increased liver adenoma incidence_Fah<tm1Mgo>/Fah<tm1Mgo>

http://metadb.riken.jp/0003324I129S7SvEvBrdC57BLFahtm1MgoFahtm1MgoFahtm1Mgo

increased liver adenoma incidence_Fah<tm1Mgo>/Fah<tm1Mgo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fumarylacetoacetate hydrolase
  http://metadb.riken.jp/db/mgi_rdf/MGI:95482

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fah<tm1Mgo>/Fah<tm1Mgo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fah<tm1Mgo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * C57BL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased liver adenoma incidence
  http://purl.obolibrary.org/obo/MP_0003324

文献

http://purl.org/net/cito/citesAsAuthority

• M. Grompe, et.al., Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I., Nature genetics, 1995, 10
  http://rdf.ncbi.nlm.nih.gov/pubmed/7545495